Guy Yachin Net Worth

Guy Yachin biography

Guy Yachin serves as Independent Director of the Company. Mr. Yachin has served as a director since his appointment on April 2, 2012. Mr. Yachin has served as the President and CEO of Serpin Pharma, a clinical stage Virginia-based company focused on the development of anti-inflammatory drugs, since April 2013. Mr. Yachin is the CEO of Oasis Management, a Maryland-based consulting company, since 2010. Mr. Yachin is the CEO of NasVax Ltd., a company focused on the development of improved immunotherapeutics and vaccines. Prior to joining NasVax, Mr. Yachin served as CEO of MultiGene Vascular Systems Ltd., a cell therapy company focused on blood vessels disorders, leading the company through clinical studies in the U.S. and Israel, financial rounds, and a keystone strategic agreement with Teva Pharmaceuticals Industries Ltd. He was CEO and founder of Chiasma Inc., a biotechnology company focused on the oral delivery of macromolecule drugs, where he built the company’s presence in Israel and the U.S., concluded numerous financial rounds, and guided the company’s strategy and operation for over six years. Earlier, he was CEO of Naiot Technological Center Ltd., and provided seed funding and guidance to more than a dozen biomedical startups such as Remon Medical Technologies Ltd., Enzymotec Ltd. and NanoPass Technologies Ltd. He holds a BSc. in Industrial Engineering and Management and an MBA from the Technion – Israel Institute of Technology. Mr. Yachin served on the board of Peak Pharmaceuticals, Inc. from March 2014 to April 2016.

What is the salary of Guy Yachin?

As the Independent Director of Orgenesis Inc, the total compensation of Guy Yachin at Orgenesis Inc is $156,998. There are 8 executives at Orgenesis Inc getting paid more, with Vered Caplan having the highest compensation of $1,577,660.

How old is Guy Yachin?

Guy Yachin is 52, he's been the Independent Director of Orgenesis Inc since 2012. There are 5 older and 5 younger executives at Orgenesis Inc. The oldest executive at Orgenesis Inc is Prof. Sarah Ferber Ph.D., 67, who is the Founder & Chief Scientific Officer.

What's Guy Yachin's mailing address?

Guy's mailing address filed with the SEC is C/O ORGENESIS INC.,, 20271 GOLDENROD LANE, GERMANTOWN, MD, 20876.

Insiders trading at Orgenesis Inc

Over the last 12 years, insiders at Orgenesis Inc have traded over $4,872,134 worth of Orgenesis Inc stock and bought 375,420 units worth $216,187 . The most active insiders traders include Sca Theodorus, Ii Sa Theodorus, eOlivier Belenger. On average, Orgenesis Inc executives and independent directors trade stock every 263 days with the average trade being worth of $1,118,704. The most recent stock trade was executed by Victor Miller on 1 April 2024, trading 25,000 units of ORGS stock currently worth $12,500.

What does Orgenesis Inc do?

orgenesis inc (orgs) is a medical device company located in 21 sparrow cir, white plains, new york, united states.

Orgenesis Inc executives and stock owners

Orgenesis Inc executives and other stock owners filed with the SEC include:

• Vered Caplan,
  Chairperson of the Board of Directors, Chief Executive Officer
• Vered Caplan M.Sc.,
  Chairperson of the Board, CEO & Pres
• Darren Head,
  Chief Executive Officer of Masthercell Global
• Neil T. Reithinger CPA,
  CFO, Sec. & Treasurer
• Denis Bedoret,
  President of Masthercell Global
• Sarah Ferber,
  Chief Scientific Officer
• Neil Reithinger,
  Chief Financial Officer, Treasurer, Secretary
• David Sidransky,
  Independent Director
• Guy Yachin,
  Independent Director
• Yaron Adler,
  Independent Director
• Ashish Nanda,
  Independent Director
• Mario Philips,
  Independent Director
• Vincent Vandamme,
  Sr. VP of Quality Strategy
• Lilach Harel,
  VP of Global HR
• Osher Partok Rheinisch,
  Gen. Counsel & Compliance Officer
• Dr. Shimon Hassin Ph.D.,
  Chief Technology Officer
• Joseph Green,
  Chief Operating Officer
• Evan Fishman,
  Chief Financial Officer
• Prof. Sarah Ferber Ph.D.,
  Founder & Chief Scientific Officer
• Elliot Maltz,
  Chief Financial Officer
• Olivier Belenger,
  
• Hugues Bultot,
  Director
• Libre De Bruxelles Universite,
  
• Ii Sa Theodorus,
  
• Sca Theodorus,
  
• Etti Hanochi,
  Director
• Itzhak Vider,
  Director
• Victor Miller,
  CHIEF FINANCIAL OFFICER
• Jacob Safier,
  10% owner
• Mark Goodman,
  Director
• Kunik Efrat Assa,
  Chief Development Officer